These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19376812)

  • 1. Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia.
    Coppola G; Marmolino D; Lu D; Wang Q; Cnop M; Rai M; Acquaviva F; Cocozza S; Pandolfo M; Geschwind DH
    Hum Mol Genet; 2009 Jul; 18(13):2452-61. PubMed ID: 19376812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.
    Marmolino D; Acquaviva F; Pinelli M; Monticelli A; Castaldo I; Filla A; Cocozza S
    Cerebellum; 2009 Jun; 8(2):98-103. PubMed ID: 19104905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.
    Huang ML; Becker EM; Whitnall M; Suryo Rahmanto Y; Ponka P; Richardson DR
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16381-6. PubMed ID: 19805308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia.
    Hayashi G; Shen Y; Pedersen TL; Newman JW; Pook M; Cortopassi G
    Hum Mol Genet; 2014 Dec; 23(25):6838-47. PubMed ID: 25104852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of FXN expression and lipolysis in white adipocytes plays a critical role in insulin sensitivity in Friedreich's ataxia mouse model.
    Wu L; Huang F; Yang L; Yang L; Sun Z; Zhang J; Xia S; Zhao H; Ding Y; Bian D; Li K
    Sci Rep; 2024 Aug; 14(1):19876. PubMed ID: 39191875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector.
    Lim F; Palomo GM; Mauritz C; Giménez-Cassina A; Illana B; Wandosell F; Díaz-Nido J
    Mol Ther; 2007 Jun; 15(6):1072-8. PubMed ID: 17375064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Prospects for Friedreich's Ataxia.
    Zhang S; Napierala M; Napierala JS
    Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
    Anzovino A; Lane DJ; Huang ML; Richardson DR
    Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemistry of cardiomyopathy in the mitochondrial disease Friedreich's ataxia.
    Lane DJ; Huang ML; Ting S; Sivagurunathan S; Richardson DR
    Biochem J; 2013 Aug; 453(3):321-36. PubMed ID: 23849057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich's ataxia.
    Weng L; Laboureur L; Wang Q; Guo L; Xu P; Gottlieb L; Lynch DR; Mesaros C; Blair IA
    Sci Rep; 2020 Sep; 10(1):15788. PubMed ID: 32978498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.
    Shan Y; Schoenfeld RA; Hayashi G; Napoli E; Akiyama T; Iodi Carstens M; Carstens EE; Pook MA; Cortopassi GA
    Antioxid Redox Signal; 2013 Nov; 19(13):1481-93. PubMed ID: 23350650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.
    Perdomini M; Belbellaa B; Monassier L; Reutenauer L; Messaddeq N; Cartier N; Crystal RG; Aubourg P; Puccio H
    Nat Med; 2014 May; 20(5):542-7. PubMed ID: 24705334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.
    Marmolino D; Acquaviva F
    Cerebellum; 2009 Sep; 8(3):245-59. PubMed ID: 19165552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review).
    Palau F
    Int J Mol Med; 2001 Jun; 7(6):581-9. PubMed ID: 11351269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia.
    Martelli A; Friedman LS; Reutenauer L; Messaddeq N; Perlman SL; Lynch DR; Fedosov K; Schulz JB; Pandolfo M; Puccio H
    Dis Model Mech; 2012 Nov; 5(6):860-9. PubMed ID: 22736457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich's ataxia.
    Alper G; Narayanan V
    Pediatr Neurol; 2003 May; 28(5):335-41. PubMed ID: 12878293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich's ataxia reveals a mechanism for coordinate regulation of oxidative metabolism via feedback inhibition of the SIRT3 deacetylase.
    Wagner GR; Pride PM; Babbey CM; Payne RM
    Hum Mol Genet; 2012 Jun; 21(12):2688-97. PubMed ID: 22394676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.